What is the current stock price of Ares Acquisition Corporation (AAC)?

As of the latest market data, Ares Acquisition Corporation (AAC) is trading at $10.79. The stock has seen a gain of 0.19% today.

Does Ares Acquisition Corporation (AAC) pay a dividend?

Based on current data, Ares Acquisition Corporation does not have a confirmed active dividend policy.

What is the market cap of Ares Acquisition Corporation?

The current market capitalization of Ares Acquisition Corporation (AAC) is approximately unavailable.

Ares Acquisition Corporation (AAC) Stock Price, News & Key Metrics

AAC NEWS

businesswire.com

Mar 20

The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®

PARIS--(BUSINESS WIRE)--Regulatory News: The 15-20 National Hospital (l'Hôpital national des 15-20) in Paris and GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that the first patients have been treated in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®.1 The REVISE.

Company Profile

Ares Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Sector

Financial Services

Industry

Shell Companies

IPO Date

2021-03-25

Beta

0.01

Websitewww.aresacquisitioncorporation.com↗